Pharmacology Watch – October 1, 2016
October 1, 2016
View Issues
-
Analysis Shows U.S. Drug Spending Far Exceeds All Other Nations
A recent study concluded there's no connection between research/development costs and prices, suggesting U.S. prescription drugs are priced primarily on the basis of what the market will bear.
-
Report: Certain Cholesterol-lowering Drugs Too Expensive
Manufacturers of these drugs would need to reduce the annual cost by nearly $10,000 per year, from $14,000 to about $4,500, to make them cost effective.
-
Connecting Calcium Supplementation to Dementia in Elderly Women
While derived from a small sample, data suggest calcium supplementation may increase the risk of developing dementia in elderly women with cerebrovascular disease.
-
Two Flu Vaccines Show Comparable Efficacy
Study shows two vaccines were of equal efficacy, at least in preventing influenza.
-
FDA Actions
In this section: FDA warns of potential lethal outcomes regarding potent drug combination, approved first biosimilar to etanercept for multiple inflammatory diseases, and bans specific chemicals in certain consumer antiseptic wash products.